Lumos Diagnostics LDXHF Stock
Lumos Diagnostics Price Chart
Lumos Diagnostics LDXHF Financial and Trading Overview
| Lumos Diagnostics stock price | 0.08 USD |
| Previous Close | 0.08 USD |
| Open | 0.08 USD |
| Bid | 0.07 USD x 3500000 |
| Ask | 0.09 USD x 3000000 |
| Day's Range | 0.08 - 0.08 USD |
| 52 Week Range | 0.02 - 0.24 USD |
| Volume | 10K USD |
| Avg. Volume | 68.03K USD |
| Market Cap | 75.48M USD |
| Beta (5Y Monthly) | 0.544 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LDXHF Valuation Measures
| Enterprise Value | 67.79M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.179836 |
| Price/Book (mrq) | 11.671428 |
| Enterprise Value/Revenue | 5.55 |
| Enterprise Value/EBITDA | -6.409 |
Trading Information
Lumos Diagnostics Stock Price History
| Beta (5Y Monthly) | 0.544 |
| 52-Week Change | 308.50% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.24 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.1 USD |
| 200-Day Moving Average | 0.15 USD |
LDXHF Share Statistics
| Avg. Volume (3 month) | 68.03K USD |
| Avg. Daily Volume (10-Days) | 4.94K USD |
| Shares Outstanding | 923.87M |
| Float | 478.38M |
| Short Ratio | N/A |
| % Held by Insiders | 19.63% |
| % Held by Institutions | 19.30% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | -75.80% |
| Operating Margin (ttm) | -106.37% |
| Gross Margin | 62.16% |
| EBITDA Margin | -86.59% |
Management Effectiveness
| Return on Assets (ttm) | -29.17% |
| Return on Equity (ttm) | -123.27% |
Income Statement
| Revenue (ttm) | 12.21M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | -3.00000000000000000000000000000000% |
| Gross Profit (ttm) | 7.59M USD |
| EBITDA | -10577000 USD |
| Net Income Avi to Common (ttm) | -9259000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.99M USD |
| Total Cash Per Share (mrq) | 0.004 USD |
| Total Debt (mrq) | 6.47M USD |
| Total Debt/Equity (mrq) | 123.66 USD |
| Current Ratio (mrq) | 0.729 |
| Book Value Per Share (mrq) | 0.007 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2254000 USD |
| Levered Free Cash Flow (ttm) | -2463750 USD |
Profile of Lumos Diagnostics
| Country | United States |
| State | CA |
| City | Carlsbad |
| Address | 2724 Loker Ave West |
| ZIP | 92010 |
| Phone | 855 586 6739 |
| Website | https://lumosdiagnostics.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Q&A For Lumos Diagnostics Stock
What is a current LDXHF stock price?
Lumos Diagnostics LDXHF stock price today per share is 0.08 USD.
How to purchase Lumos Diagnostics stock?
You can buy LDXHF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lumos Diagnostics?
The stock symbol or ticker of Lumos Diagnostics is LDXHF.
Which industry does the Lumos Diagnostics company belong to?
The Lumos Diagnostics industry is Medical Devices.
How many shares does Lumos Diagnostics have in circulation?
The max supply of Lumos Diagnostics shares is 944.39M.
What is Lumos Diagnostics Price to Earnings Ratio (PE Ratio)?
Lumos Diagnostics PE Ratio is now.
What was Lumos Diagnostics earnings per share over the trailing 12 months (TTM)?
Lumos Diagnostics EPS is -0.01 USD over the trailing 12 months.
Which sector does the Lumos Diagnostics company belong to?
The Lumos Diagnostics sector is Healthcare.